Millipore Sigma Vibrant Logo

529573 PP2 - CAS 172889-27-9 - Calbiochem

Descripción

Replacement Information

Tabla espec. clave

CAS #Empirical Formula
172889-27-9C₁₅H₁₆ClN₅

Precios y disponibilidad

Número de referencia DisponiblidadEmbalaje Cant./Env. Precio Cantidad
529573-1MG
Comprobando disponibilidad...
Disponibilidad a confirmar
Disponibilidad a confirmar
Ingrese cantidad 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service

      Ampolla de plást. 1 mg
      Recuperando precio...
      No pudo obtenerse el precio
      La cantidad mínima tiene que ser múltiplo de
      Maximum Quantity is
      Al finalizar el pedido Más información
      Ahorró ()
       
      Solicitar precio
      529573-5MG
      Comprobando disponibilidad...
      Disponibilidad a confirmar
Disponibilidad a confirmar
      Ingrese cantidad 
      Suspendido
      Cantidades limitadas disponibles
      Debe confirmarse disponibilidad
        El resto: se avisará
          El resto: se avisará
          Se avisará
          Póngase en contacto con el Servicio de Atención al Cliente
          Contact Customer Service

          Frasco de vidrio 5 mg
          Recuperando precio...
          No pudo obtenerse el precio
          La cantidad mínima tiene que ser múltiplo de
          Maximum Quantity is
          Al finalizar el pedido Más información
          Ahorró ()
           
          Solicitar precio
          Description
          OverviewA potent, reversible, ATP-competitive, and selective inhibitor of the Src family of protein tyrosine kinases. Inhibits p56lck (IC50 = 4 nM), p59fynT (IC50 = 5 nM), Hck (IC50 = 5 nM), and Src (IC50 = 100 nM). Does not significantly affect the activity of EGFR kinase (IC50 = 480 nM), JAK2 (IC50 > 50 µM), or ZAP-70 (IC50 >100 µM). Inhibits the activation of focal adhesion kinase and its phosphorylation at Tyr577. Also potently inhibits anti-CD3-stimulated tyrosine phosphorylation of human T cells (IC50 = 600 nM). A 10 mM (1 mg/331 µl) solution of PP2 (Cat. No. 529576) in DMSO also available.
          Catalogue Number529573
          Brand Family Calbiochem®
          SynonymsAG 1879, 4-Amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine
          References
          ReferencesKarni, R., et al. 2003. FEBS Lett. 537, 47.
          Salazar, E.P., and Rozengurt, E. 1999. J. Biol. Chem. 274, 28371.
          Hanke, J.H., et al. 1996. J. Biol. Chem. 271, 695.



          Selected Citations
          Lee, J., et al. 2009. Cell Stem Cell 5, 76.


          Product Information
          CAS number172889-27-9
          ATP CompetitiveY
          FormOff-white solid
          Hill FormulaC₁₅H₁₆ClN₅
          Chemical formulaC₁₅H₁₆ClN₅
          ReversibleY
          Structure formula ImageStructure formula Image
          Quality LevelMQ100
          Applications
          Biological Information
          Primary Target p56lck
          Primary Target IC<sub>50</sub>4 nM, 5 nM, 5 nM, 100 nM, against p56lck, p59fynT, Hck, and Src, respectively; 600 nM against anti-CD3-stimulated tyrosine phosphorylation of human T cells
          Purity≥95% by HPLC
          Physicochemical Information
          Cell permeableN
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Ambient Temperature Only
          Toxicity Standard Handling
          Storage -20°C
          Do not freeze Ok to freeze
          Special InstructionsFollowing reconstitution, refrigerate (4°C). Stock solutions are stable for up to 6 months at 4°C.
          Packaging Information
          Packaged under inert gas Packaged under inert gas
          Transport Information
          Supplemental Information
          Specifications
          Global Trade Item Number
          Número de referencia GTIN
          529573-1MG 07790788051198
          529573-5MG 04055977269802

          Documentation

          PP2 - CAS 172889-27-9 - Calbiochem Ficha datos de seguridad (MSDS)

          Título

          Ficha técnica de seguridad del material (MSDS) 

          PP2 - CAS 172889-27-9 - Calbiochem Certificados de análisis

          CargoNúmero de lote
          529573

          Referencias bibliográficas

          Visión general referencias
          Karni, R., et al. 2003. FEBS Lett. 537, 47.
          Salazar, E.P., and Rozengurt, E. 1999. J. Biol. Chem. 274, 28371.
          Hanke, J.H., et al. 1996. J. Biol. Chem. 271, 695.



          Selected Citations
          Lee, J., et al. 2009. Cell Stem Cell 5, 76.


          Folleto

          Cargo
          An Introduction to Inhibitors and Their Biological Applications - 1st Edition
          Bulk Product Guide

          Licencias necesarias e Información técnica

          Cargo
          Fluorescent Gelatin Degradation Assays for Investigating Invadopodia Formation

          Ficha técnica

          Cargo
          Reprogramming Cell Fate and Function Novel Strategies for iPSC Generation, Characterization, and Differentiation

          Póster

          Cargo
          Human Kinome & InhibitorSelect™ Libraries

          Citas

          Título
        • Dance, M., et al. 2006. Journal of Biological Chemistry 281, 23285.
        • Fukumoto, S., et al. 2006. Journal of Biological Chemistry 281, 5008.
        • Heiss, E., et al. 2006. Blood 108, 1542.
        • Jafri, F., et al. 2006. Journal of Biological Chemistry 281, 19346.
        • Olivera, A., et al. 2006. Journal of Biological Chemistry 281, 2515.
        • Rayala, S.K. et al. 2006. Journal of Biological Chemistry 281, 4395.
        • Ellen J. Tisdale and Cristina R. Artalejo. 2006. Journal of Biological Chemistry 281, 8436.
        • Meyn, M.A., et al. 2005. Molecular Pharmacology 68, 1320.
        • Summy, J.M., et al. 2005. Molecular Cancer Therapeutics 4, 1900.
        • Trevino, J.G., et al. 2005. Cancer Research 65, 7214.
        • Liao, X., et al. 2003. Endocrinology 144, 1656.
        • Cross, M.J., et al. 2002. Molecular Biology of the Cell 13, 2881.
        • Ficha técnica

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision12-January-2010 RFH
          SynonymsAG 1879, 4-Amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine
          DescriptionA potent, reversible, ATP-competitive, and selective inhibitor of the src family of tyrosine kinases that is similar to PP1. Selectively inhibits p56lck (IC50 = 4 nM), p59fynT (IC50 = 5 nM), Hck (IC50 = 5 nM), and Src (IC50 = 100 nM) compared to other tyrosine kinases, such as EGF-R (IC50 = 480 nM), JAK2 (IC50 >50 µM) or ZAP-70 (IC50 >100 µM). Also potently inhibits anti-CD3-stimulated tyrosine phosphorylation of human T cells (IC50 = 600 nM).
          FormOff-white solid
          Intert gas (Yes/No) Packaged under inert gas
          CAS number172889-27-9
          Chemical formulaC₁₅H₁₆ClN₅
          Structure formulaStructure formula
          Purity≥95% by HPLC
          SolubilityDMSO (20 mg/ml). Further dilute with aqueous buffers just prior to use.
          Storage -20°C
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing reconstitution, refrigerate (4°C). Stock solutions are stable for up to 6 months at 4°C.
          Toxicity Standard Handling
          ReferencesKarni, R., et al. 2003. FEBS Lett. 537, 47.
          Salazar, E.P., and Rozengurt, E. 1999. J. Biol. Chem. 274, 28371.
          Hanke, J.H., et al. 1996. J. Biol. Chem. 271, 695.



          Selected Citations
          Lee, J., et al. 2009. Cell Stem Cell 5, 76.


          Citation
        • Dance, M., et al. 2006. Journal of Biological Chemistry 281, 23285.
        • Fukumoto, S., et al. 2006. Journal of Biological Chemistry 281, 5008.
        • Heiss, E., et al. 2006. Blood 108, 1542.
        • Jafri, F., et al. 2006. Journal of Biological Chemistry 281, 19346.
        • Olivera, A., et al. 2006. Journal of Biological Chemistry 281, 2515.
        • Rayala, S.K. et al. 2006. Journal of Biological Chemistry 281, 4395.
        • Ellen J. Tisdale and Cristina R. Artalejo. 2006. Journal of Biological Chemistry 281, 8436.
        • Meyn, M.A., et al. 2005. Molecular Pharmacology 68, 1320.
        • Summy, J.M., et al. 2005. Molecular Cancer Therapeutics 4, 1900.
        • Trevino, J.G., et al. 2005. Cancer Research 65, 7214.
        • Liao, X., et al. 2003. Endocrinology 144, 1656.
        • Cross, M.J., et al. 2002. Molecular Biology of the Cell 13, 2881.